Administration of Intravenous Iron Formulations Induces Complement Activation in-vivo

Background: Intravenous (IV) iron is widely used to treat anemia in chronic kidney disease patients. Previously, iron formulations were shown to induce immune activation in-vitro. The current study aimed to investigate the effect of IV iron on complement activation in-vivo, and whether this subseque...

Descripción completa

Detalles Bibliográficos
Autores principales: Faria, Bernardo, Gaya da Costa, Mariana, Poppelaars, Felix, Franssen, Casper F. M., Pestana, Manuel, Berger, Stefan P., Daha, Mohamed R., Gaillard, Carlo A. J. M., Seelen, Marc A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712170/
https://www.ncbi.nlm.nih.gov/pubmed/31497011
http://dx.doi.org/10.3389/fimmu.2019.01885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712170/
https://www.ncbi.nlm.nih.gov/pubmed/31497011
http://dx.doi.org/10.3389/fimmu.2019.01885

Ejemplares similares